{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:36:11Z","timestamp":1780727771560,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7254351"],"award-info":[{"award-number":["7254351"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s44313-025-00111-4","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T03:25:29Z","timestamp":1765250729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prophylactic donor lymphocyte infusions after first allogeneic hematopoietic stem cell transplantation in children with acute leukemia"],"prefix":"10.1007","volume":"61","author":[{"given":"Ang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhuo","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoquan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"12","key":"111_CR1","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","volume":"112","author":"HJ Kolb","year":"2008","unstructured":"Kolb HJ. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood. 2008;112(12):4371\u201383.","journal-title":"Blood"},{"issue":"16","key":"111_CR2","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","volume":"120","author":"U Creutzig","year":"2012","unstructured":"Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012;120(16):3187\u2013205.","journal-title":"Blood"},{"issue":"1","key":"111_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bjh.12900","volume":"166","author":"H Hasle","year":"2014","unstructured":"Hasle H. A critical review of which children with acute myeloid leukaemia need stem cell procedures. Br J Haematol. 2014;166(1):23\u201333.","journal-title":"Br J Haematol"},{"issue":"3","key":"111_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbmt.2016.11.022","volume":"23","author":"G Lucchini","year":"2017","unstructured":"Lucchini G, Labopin M, Beohou E, et al. Impact of conditioning regimen on outcomes for children with acute myeloid leukemia undergoing transplantation in first complete remission. An analysis on behalf of the pediatric disease working party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2017;23(3):467\u201374.","journal-title":"Biol Blood Marrow Transplant"},{"key":"111_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fimmu.2020.00147","volume":"11","author":"PE Rovatti","year":"2020","unstructured":"Rovatti PE, Gambacorta V, Lorentino F, Ciceri F, Vago L. Mechanisms of leukemia immune evasion and their role in relapse after haploidentical hematopoietic cell transplantation. Front Immunol. 2020;11:147.","journal-title":"Front Immunol"},{"issue":"5","key":"111_CR6","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, et al. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995;86(5):2041\u201350.","journal-title":"Blood"},{"issue":"1","key":"111_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3324\/haematol.2019.219790","volume":"105","author":"B Dholaria","year":"2020","unstructured":"Dholaria B, Savani BN, Labopin M, et al. Clinical applications of donor lymphocyte transfusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT. Haematologica. 2020;105(1):47\u201358.","journal-title":"Haematologica"},{"issue":"5","key":"111_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/bmt.2015.234","volume":"51","author":"Z Jedlickova","year":"2016","unstructured":"Jedlickova Z, Schmid C, Koenecke C, et al. Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation. Bone Marrow Transplant. 2016;51(5):663\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"111_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transplant. 2016;22(1):4\u201310.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"111_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. the 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389-401.e1.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"111_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00277-023-05506-w","volume":"103","author":"J Tian","year":"2024","unstructured":"Tian J, Wei A, Wang B, et al. Allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia. Ann Hematol. 2024;103(1):297\u2013305.","journal-title":"Ann Hematol"},{"issue":"1","key":"111_CR12","doi-asserted-by":"publisher","first-page":"2406596","DOI":"10.1080\/16078454.2024.2406596","volume":"29","author":"H He","year":"2024","unstructured":"He H, Li J, Li W, et al. Clinical features and long-term outcomes of pediatric patients with de novo acute myeloid leukemia in China with or without specific gene abnormalities: a cohort study of patients treated with BCH-AML 2005. Hematology. 2024;29(1):2406596.","journal-title":"Hematology"},{"issue":"1","key":"111_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41409-022-01839-8","volume":"58","author":"N Santoro","year":"2023","unstructured":"Santoro N, Mooyaart JE, Devillier R, et al. Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: a study on behalf of the EBMT cellular therapy & immunobiology working party. Bone Marrow Transplant. 2023;58(1):54\u201360.","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"111_CR14","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/bmt.2016.167","volume":"51","author":"P Tsirigotis","year":"2016","unstructured":"Tsirigotis P, Byrne M, Schmid C, et al. Relapse of AML after hematopoietic stem cell transplantation: Methods of monitoring preventive strategies A review from the ALWP of the. EBMT Bone Marrow Transpl. 2016;51(11):1431\u20138.","journal-title":"EBMT Bone Marrow Transpl"},{"issue":"11","key":"111_CR15","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1182\/blood-2007-02-072470","volume":"109","author":"A Dominietto","year":"2007","unstructured":"Dominietto A, Pozzi S, Miglino M, et al. Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia. Blood. 2007;109(11):5063\u20134.","journal-title":"Blood"},{"key":"111_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2016.12.004","volume":"48","author":"G Orti","year":"2017","unstructured":"Orti G, Barba P, Fox L, Salamero O, Bosch F, Valcarcel D. Donor lymphocyte infusions in AML and MDS: enhancing the graft-versusleukemia effect. Exp Hematol. 2017;48:1\u201311.","journal-title":"Exp Hematol"},{"issue":"5","key":"111_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018;378(5):439\u201348.","journal-title":"N Engl J Med"},{"issue":"3","key":"111_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000534315","volume":"147","author":"L Minculescu","year":"2024","unstructured":"Minculescu L, Reekie J, Petersen SL, et al. Donor lymphocyte infusion is a feasible way to improve survival in patients with acute myeloid leukemia and myelodysplastic syndromes who relapse after allogeneic stem cell transplantation. Acta Haematol. 2024;147(3):325\u201332.","journal-title":"Acta Haematol"},{"issue":"2","key":"111_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/08880018.2020.1829220","volume":"38","author":"E Huschart","year":"2021","unstructured":"Huschart E, Miller H, Salzberg D, et al. Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia. Pediatr Hematol Oncol. 2021;38(2):154\u201360.","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"111_CR20","doi-asserted-by":"publisher","first-page":"e14293","DOI":"10.1111\/petr.14293","volume":"26","author":"R Chandar","year":"2022","unstructured":"Chandar R, Meena S, Varla H, et al. Post-transplant strategies to improve relapse-free survival in childhood leukemia: whole blood donor lymphocyte infusions and lenalidomide for inducing graft-versus-leukemia effect. Pediatr Transplant. 2022;26(5):e14293.","journal-title":"Pediatr Transplant"},{"issue":"9","key":"111_CR21","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1200\/JCO.2004.05.198","volume":"22","author":"P Bader","year":"2004","unstructured":"Bader P, Kreyenberg H, et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy. J Clin Oncol. 2004;22(9):1696\u2013705.","journal-title":"J Clin Oncol"},{"issue":"7","key":"111_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/bmt.2017.45","volume":"52","author":"A Liou","year":"2017","unstructured":"Liou A, Wahlstrom JT, Dvorak CC, Horn BN. Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies. Bone Marrow Transplant. 2017;52(7):1057\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"111_CR23","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1038\/bcj.2013.39","volume":"3","author":"P Rujkijyanont","year":"2013","unstructured":"Rujkijyanont P, Morris C, Kang G, et al. Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia. Blood Cancer J. 2013;3(8):e137.","journal-title":"Blood Cancer J"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-025-00111-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44313-025-00111-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-025-00111-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:02:25Z","timestamp":1767708145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44313-025-00111-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1007\/s44313-025-00111-4","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of Beijing Children\u2019s Hospital, Capital Medical University. Informed consent to participate in the study was obtained from the parents or legal guardians of children under 16\u00a0years of age.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}